4//SEC Filing
Keenan Greg 4
Accession 0001600620-25-000026
CIK 0001600620other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:25 PM ET
Size
5.2 KB
Accession
0001600620-25-000026
Insider Transaction Report
Form 4
Keenan Greg
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-03-07$8.23/sh−8,305$68,350→ 153,484 total
Footnotes (2)
- [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 6, 2023 grant.
- [F2]The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0002044006
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:25 PM ET
- Size
- 5.2 KB